Voluntary recall of infants' ibuprofen expanded
Tris Pharma has expanded its voluntary recall of infants' ibuprofen oral suspension drops over concerns the concentration of ibuprofen in some of the batches is too high.
•
Jan 31, 2019, 12:41 PM
•
Updated 2,151 days ago
Share:
Tris Pharma has expanded its voluntary recall of infants' ibuprofen oral suspension drops over concerns the concentration of ibuprofen in some of the batches is too high.
The concentration can be as high as 10 percent above the specified limit.
The affected brands include CVS health and Equate, which is sold at Walmart.
For information, click here.
More from News 12
1:54
STORM WATCH: Morning snow followed by deep cold in New Jersey
0:19
Police: Hoboken shooting suspect charged with attempted murder
Government funding bill clears Congress and heads to President Biden, averting a shutdown
1:28
FDA announces new criteria for what foods can be considered healthy
0:15
Police: Music building burglarized on Rutgers-New Brunswick campus
1:51
